Oric Pharmaceuticals, Inc. ORIC Payments Of Stock Issuance Costs
Payments Of Stock Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s payments of stock issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s payments of stock issuance costs?
- Oric Pharmaceuticals, Inc. (ORIC) reported payments of stock issuance costs of $993K in Q1 2026.
- What does payments of stock issuance costs mean?
- This metric captures the direct costs incurred by the company to raise capital through the issuance of equity, such as underwriting fees, legal expenses, and registration costs. These outflows represent the friction costs associated with accessing public capital markets. Monitoring these costs helps investors understand the efficiency of the company's capital-raising activities.